# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-08T12:18:55.753274
**Route:** OpenRouter + LaTeX
**Tokens:** 23153 in / 1777 out
**Response SHA256:** 7b5c21ee15da00bc

---

I reviewed the draft for fatal errors according to your checklist (data-design alignment, regression sanity, completeness, internal consistency). I focused only on the potential show-stoppers that would embarrass the author or make the submission impossible to evaluate. I did not comment on prose, novelty, minor choices, or interpretive issues.

Findings (summary)
- I found no fatal errors. The paper's treatment timing is consistent with the data coverage; regression tables do not contain impossible values (no NaN/Inf, no negative SEs, no R² outside [0,1] reported), key sample sizes and standard errors are reported, and there are no placeholder values (NA / TODO / XXX) in tables or figures. References to tables and figures resolve to existing labels. Cohort/treatment definitions are consistently described and coded in the data section and appendix.

Checks performed (high-level evidence)

1) Data-design alignment
- The sample window is 2015Q1–2024Q4 and the paper explicitly codes treatment at the quarter of effective date (or the following quarter when effective date is not the first day of a quarter). The manuscript consistently treats laws effective after 2024Q4 as not-yet-treated. The set of seven "effectively treated" states (CA, VA, CO, CT, UT, OR, TX) is consistently described where it matters for identification. Montana (effective Oct 1, 2024) is explicitly reclassified as not-yet-treated; that choice is explained and consistently referenced. I checked the stated rule (first full quarter of exposure) and it matches the examples in text (e.g., Utah coded 2024Q1). Max(treatment year) ≤ max(data year) is respected by the coding strategy; non-2024 effective dates are handled as not-yet-treated.

2) Regression sanity
- Scanned all tables and reported SEs / coefficients:
  - No standard error > 1000, none implausibly large relative to coefficients.
  - No coefficient magnitude exceeds thresholds flagged as fatal (e.g., |coef| > 100 for any outcome, or |coef| > 10 for log outcomes). Largest magnitudes are well within reasonable ranges (e.g., -0.1833 with SE 0.0330).
  - No negative standard errors, no NA/NaN/Inf in tables.
  - Table N's are reported (e.g., Table 4 N = 2,040 for BFS) and per-industry observation counts are given where disclosure suppression affects the panel.
  - Clustered SEs and alternative inference procedures are reported; nothing indicates an arithmetic/printing error.

3) Completeness
- No "TODO", "TBD", "PLACEHOLDER", "XXX", or similar placeholders in tables, figures, or text.
- Regression tables report standard errors and N; figures referenced in the text exist with labels used consistently.
- Robustness checks and sensitivity analyses are reported or explicitly noted when a procedure did not converge (HonestDiD), which is acceptable as it is transparently reported rather than left as a placeholder.

4) Internal consistency
- Treatment timing consistent across text, tables, and appendix treatment-timing table.
- Numbers cited in text (e.g., -7.7% effect on Software Publishers) match values in Table 3 Panel B (CS-DiD ATT = -0.0767).
- Statements about which states contribute post-treatment variation and the influence of California are consistently applied across results, cohort decomposition, and robustness sections.

Minor inconsistencies/non-fatal items (non-blocking; optional fixes)
- A few passages use slightly different wording about the total number of adopted states (e.g., "eighteen additional states" vs. "nineteen states have enacted"); these are editorial clarity issues rather than fatal mismatches in the empirical setup. (Not fatal; fix for clarity.)
- The manuscript sometimes refers to the 19 ever-enacted states and elsewhere to 18 additional states beyond California; this is a textual minor inconsistency to clean up.
- The HonestDiD routine's failure to converge is explained; that is not fatal but should be signposted clearly in the abstract or main results as a limitation (already discussed).

Conclusion
- I found ZERO fatal errors according to the four categories required for this review.

ADVISOR VERDICT: PASS